Network marketing company Nature’s Sunshine reported disappointing earnings yesterday, driven mostly by a protracted and difficult software switchover, according to management.
Despite a high profile legal wrangle with FTC and with the New York Attorney General, memory support supplement manufacturer Quincy Bioscience has enough revenue in the tank to afford a high-dollar sponsorship of a NASCAR racing team.
Investment interest in the dietary supplement industry remains high, with the latest news being the sale of majority control of The Nature’s Bounty Co. to private equity firm KKR.
The botanicals sector is thriving, in part because it is hooking onto broader trends in the culture. That’s the message that audience members received during a webinar yesterday.
Nutraceutical International Corporation’s longtime aggressive acquisition strategy has borne the ultimate fruit in the announcement today that the company will be sold to a private equity firm for $446 million.
Herbalife has shaken off the lingering effects of a big-ticket settlement with the Federal Trade Commission with a relatively solid quarterly results statement that was welcomed by stock traders.
ChromaDex has reported a rapid rise in sales driven mainly by its Niagen ingredient. But the company continues to post losses, and the stock price has failed to recover from a steep slide more than nine months ago.
Company to sell 60% stake in Dairy Ireland to Irish co-op
Glanbia reported better than expected growth in 2016 with performance nutrition driving revenue and profits, said the firm as it announced the part sell-off of its Irish dairy business.
